Scalp Biopsy Identifies Systemic Amyloidosis Presenting as Isolated Telogen Effluvium: A Case Report

    January 2019 in “ SAGE Open Medical Case Reports
    Rory Sutherland, Richard Crawford
    Image of study
    TLDR A scalp biopsy revealed systemic amyloidosis in a woman who initially seemed to have a common hair loss condition.
    In 2019, a case report described a 74-year-old woman who presented with diffuse scalp alopecia, initially suspected to be telogen effluvium or diffuse alopecia areata. However, scalp biopsies revealed a large proportion of hair follicles in the catagen and telogen phases, with no signs of scarring alopecia. Remarkably, the biopsies also showed perifollicular deposition of amyloid, which is characteristic of systemic amyloidosis. This prompted further investigation, leading to the diagnosis of lambda AL amyloidosis, a type of systemic amyloidosis associated with B-cell dyscrasias or multiple myeloma. The patient was found to have an occult plasma-cell dyscrasia with 8% plasma cells in the bone marrow and received treatment with melphalan. The case highlights the importance of considering systemic amyloidosis in the differential diagnosis of alopecia and demonstrates the utility of scalp biopsy in identifying underlying systemic conditions. The patient's disease was stable at the time of publication, with no known involvement of major organs except for mild renal impairment and proteinuria.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 406 results

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  37 upvotes 1 year ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

      community any news about DUPA (Diffuse unpatterned alopecia)?

      in Research/Science  11 upvotes 1 year ago
      The conversation discusses diffuse unpatterned alopecia (DUPA) and its possible causes, including sensitivity to DHT, not being androgenic alopecia, being diffuse alopecia areata, or hormonal issues. Treatments mentioned include topical melatonin, Clobetasol Propionate for alopecia areata, and the lack of results from using finasteride, dutasteride, and minoxidil.
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 3 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community I am a dermatologist with a clinical interest in alopecia. AMA

      in Will treatment work for me? 2 years ago
      In this conversation, 4990 discussed various treatments for hair loss, including oral minoxidil, PRP, transplan, Jak inhibitors, Dutasteride, Finasteride, Olumiant, Ketoconazole, RU58841, microneedling, baricitinib, and CCCA. They recommended scalp biopsies in unclear cases of DUPA, twice weekly to twice daily shampooing for topical minoxidil users, and two sessions spaced one month apart with follow up at month three to determine the effectiveness of PRP treatment.

      community Is there any chance of improvement?

      in Minoxidil  7 upvotes 2 years ago
      A 19-year-old experiencing severe hair loss since 16 is using a treatment regimen of 5% minoxidil, 0.1% finasteride topical solution, 3% procapil hair serum, and 0.5 mg dutasteride daily. They are concerned about the effectiveness and potential shedding phase, with advice suggesting noticeable changes in 6 to 8 months.

    Similar Research

    5 / 1000+ results